作者
Ava Ziaei, Parivash Davoodian, Habib Dadvand, Omid Safa, Soheil Hassanipour, Mahmoud Omidi, Moein Masjedi, Fahime Mahmoudikia, Bahareh Rafiee, Mohammad Fathalipour
发表日期
2020/12
期刊
Trials
卷号
21
页码范围
1-3
出版商
BioMed Central
简介
Objectives
We will evaluate the efficacy and safety of Melatonin, compared to the standard therapeutic regimen on clinical symptoms and serum inflammatory parameters in patients with confirmed COVID-19, who are moderately ill.
Trial design
This is a single-center, randomized, double-blind, placebo-controlled clinical trial with a parallel-group design conducted at Shahid Mohammadi Hospital, Bandar Abbas, Iran.
Participants
All patients admitted to Severe Acute Respiratory Syndrome Departments of Shahid Mohammadi Hospital, Bandar Abbas, Iran will be screened for the following criteria.
Inclusion criteria:
1. Age ≥20 years
2. Confirmed SARS-CoV-2 diagnosis (positive polymerase chain reaction).
3. Moderate COVID-19 pneumonia (via computed tomography and or X-ray imaging), requiring hospitalization.
4. Hospitalized ≤48 hours.
5. Signing informed consent and willingness of the participant to …
学术搜索中的文章
A Ziaei, P Davoodian, H Dadvand, O Safa… - Trials, 2020